Nobuhiro Kanemura

1.6k total citations
70 papers, 1.0k citations indexed

About

Nobuhiro Kanemura is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Nobuhiro Kanemura has authored 70 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pathology and Forensic Medicine, 22 papers in Oncology and 13 papers in Genetics. Recurrent topics in Nobuhiro Kanemura's work include Lymphoma Diagnosis and Treatment (35 papers), Viral-associated cancers and disorders (12 papers) and CNS Lymphoma Diagnosis and Treatment (11 papers). Nobuhiro Kanemura is often cited by papers focused on Lymphoma Diagnosis and Treatment (35 papers), Viral-associated cancers and disorders (12 papers) and CNS Lymphoma Diagnosis and Treatment (11 papers). Nobuhiro Kanemura collaborates with scholars based in Japan and United States. Nobuhiro Kanemura's co-authors include Hisashi Tsurumi, Hisataka Moriwaki, Senji Kasahara, Naoe Goto, Masahito Shimizu, Takeshi Hara, Tsuyoshi Takami, Toshiki Yamada, Michio Sawada and Junichi Kitagawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gut.

In The Last Decade

Nobuhiro Kanemura

62 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nobuhiro Kanemura Japan	20	348	331	248	199	146	70	1.0k
Naoe Goto Japan	22	470 1.4×	397 1.2×	199 0.8×	238 1.2×	190 1.3×	66	1.2k
Kimio Terao Japan	9	71 0.2×	264 0.8×	131 0.5×	220 1.1×	71 0.5×	24	861
Yayoi Shikama Japan	16	77 0.2×	221 0.7×	183 0.7×	278 1.4×	91 0.6×	54	1.0k
Akihiro Iguchi Japan	18	70 0.2×	219 0.7×	173 0.7×	169 0.8×	185 1.3×	84	1.0k
Wen‐Chan Tsai Taiwan	20	170 0.5×	171 0.5×	248 1.0×	466 2.3×	65 0.4×	82	1.3k
Florian Bösch Germany	16	96 0.3×	412 1.2×	213 0.9×	105 0.5×	206 1.4×	49	1.0k
John M. Goldberg United States	11	156 0.4×	711 2.1×	212 0.9×	149 0.7×	285 2.0×	25	1.3k
Barbara Maria Colombo Italy	17	108 0.3×	69 0.2×	158 0.6×	389 2.0×	130 0.9×	35	979
Ayşe Dursun Türkiye	21	169 0.5×	274 0.8×	228 0.9×	60 0.3×	214 1.5×	82	1.2k
Jeong Hae Kie South Korea	16	183 0.5×	65 0.2×	181 0.7×	155 0.8×	116 0.8×	56	788

Countries citing papers authored by Nobuhiro Kanemura

Since Specialization

Citations

This map shows the geographic impact of Nobuhiro Kanemura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Kanemura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Kanemura more than expected).

Fields of papers citing papers by Nobuhiro Kanemura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiro Kanemura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Kanemura. The network helps show where Nobuhiro Kanemura may publish in the future.

Co-authorship network of co-authors of Nobuhiro Kanemura

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiro Kanemura. A scholar is included among the top collaborators of Nobuhiro Kanemura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiro Kanemura. Nobuhiro Kanemura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fukuno, Kenji, et al.. (2026). Acquired Pure Red Cell Aplasia Following BNT162b2 mRNA COVID-19 Vaccination. Internal Medicine. 65(4). 569–572.

Nakamura, Nobuhiko, Nobuhiro Kanemura, Takuro Matsumoto, et al.. (2024). Effect of Vitamin D and Skeletal Muscle Mass on Prognosis of Patients with Diffuse Large B-Cell Lymphoma. Nutrients. 16(16). 2653–2653.

Kanemura, Nobuhiro, Nobuhiko Nakamura, Yuhei Shibata, et al.. (2023). The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 65(3). 339–345. 4 indexed citations

Nakamura, Nobuhiko, Nobuhiro Kanemura, Takayuki Goto, et al.. (2023). Prognostic Impact of Skeletal Muscle Index and Vitamin D in Diffuse Large B-Cell Lymphoma. Blood. 142(Supplement 1). 3109–3109. 1 indexed citations

Nakamura, Nobuhiko, Nobuhiro Kanemura, Takuro Matsumoto, et al.. (2023). Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population. Scientific Reports. 13(1). 19060–19060. 2 indexed citations

Nakamura, Hiroshi, Takeshi Hara, Takuro Matsumoto, et al.. (2021). Clinical significance of oxidative stress for untreated patients with diffuse large B‑cell lymphoma. Molecular and Clinical Oncology. 16(1). 4–4. 3 indexed citations

Sakai, Hiroyasu, Takao Miwa, Tatsunori Hanai, et al.. (2020). Development of diffuse large B‑cell lymphoma after sofosbuvir‑ledipasvir treatment for chronic hepatitis C: A case report and literature review. Molecular and Clinical Oncology. 13(3). 1–1. 3 indexed citations

Nakamura, Nobuhiko, Takeshi Hara, Yuhei Shibata, et al.. (2015). Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma. Annals of Hematology. 94(12). 2043–2053. 79 indexed citations

Hayashi, Hiroko, Ryo Kobayashi, Akio Suzuki, et al.. (2014). Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation.. PubMed. 34(12). 7271–7. 19 indexed citations

10.

Goto, Naoe, Hisashi Tsurumi, Senji Kasahara, et al.. (2011). Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens. European Journal Of Haematology. 87(3). 217–227. 23 indexed citations

11.

Tsurumi, Hisashi, Takeshi Hara, Naoe Goto, et al.. (2011). A phase II study of rituximab combined with pirarubicin–cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma. Leukemia & lymphoma. 53(2). 247–253. 2 indexed citations

12.

Ninomiya, Soranobu, Nobuhiro Kanemura, Hisashi Tsurumi, et al.. (2011). Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis. International Journal of Hematology. 93(6). 806–810. 11 indexed citations

13.

Ninomiya, Soranobu, Kenji Fukuno, Nobuhiro Kanemura, et al.. (2010). IgG Type Multiple Myeloma and Concurrent IgA Type Monoclonal Gammopathy of Undetermined Significance Complicated by Necrotizing Skin Ulcers due to Type I Cryoglobulinemia. Journal of Clinical and Experimental Hematopathology. 50(1). 71–74. 6 indexed citations

14.

Kitagawa, Junichi, Takeshi Hara, Hisashi Tsurumi, et al.. (2010). Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2. Journal of Cancer Research and Clinical Oncology. 137(5). 779–787. 11 indexed citations

15.

Kitagawa, Junichi, Takeshi Hara, Hisashi Tsurumi, et al.. (2010). Cell Cycle-Dependent Priming Action of Granulocyte Colony-Stimulating Factor (G-CSF) Enhances in vitro Apoptosis Induction by Cytarabine and Etoposide in Leukemia Cell Lines. Journal of Clinical and Experimental Hematopathology. 50(2). 99–105. 13 indexed citations

16.

Hara, Takeshi, Hisashi Tsurumi, Naoe Goto, et al.. (2009). Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP. Journal of Cancer Research and Clinical Oncology. 135(10). 1421–1428. 12 indexed citations

17.

Yoshikawa, Takeshi, Takeshi Hara, Hisashi Tsurumi, et al.. (2009). Serum concentration of L‐kynurenine predicts the clinical outcome of patients with diffuse large B‐cell lymphoma treated with R‐CHOP. European Journal Of Haematology. 84(4). 304–309. 61 indexed citations

18.

Kanemura, Nobuhiro, Hisashi Tsurumi, Senji Kasahara, et al.. (2007). Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony‐stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy. Hematological Oncology. 26(1). 33–38. 7 indexed citations

19.

Fukuno, Kenji, Hisashi Tsurumi, Nobuhiro Ando, et al.. (2006). Late-Onset Neutropenia in Patients Treated with Rituximab for Non-Hodgkin's Lymphoma. International Journal of Hematology. 84(3). 242–247. 27 indexed citations

20.

Kojima, Yasushi, Hisashi Tsurumi, Naoe Goto, et al.. (2006). Fas and Fas ligand expression on germinal center type‐diffuse large B‐cell lymphoma is associated with the clinical outcome. European Journal Of Haematology. 76(6). 465–472. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact